B Fuchsova1, A Alvarez Juliá2, H S Rizavi3, A C Frasch2, G N Pandey3. 1. Instituto de Investigaciones Biotecnológicas, CONICET-UNSAM, 1650 San Martin, Argentina. Electronic address: beata@iibintech.com.ar. 2. Instituto de Investigaciones Biotecnológicas, CONICET-UNSAM, 1650 San Martin, Argentina. 3. Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60612, USA.
Abstract
BACKGROUND: Expression of the neuronal membrane glycoprotein M6a (GPM6A), the proteolipid protein (PLP/DM20) family member, is downregulated in the hippocampus of chronically stressed animals. Its neuroplastic function involves a role in neurite formation, filopodium outgrowth and synaptogenesis through an unknown mechanism. Disruptions in neuroplasticity mechanisms have been shown to play a significant part in the etiology of depression. Thus, the current investigation examined whether GPM6A expression is also altered in human depressed brain. METHODS: Expression levels and coexpression patterns of GPM6A, GPM6B, and PLP1 (two other members of PLP/DM20 family) as well as of the neuroplasticity-related genes identified to associate with GPM6A were determined using quantitative polymerase chain reaction (qPCR) in postmortem samples from the hippocampus (n = 18) and the prefrontal cortex (PFC) (n = 25) of depressed suicide victims and compared with control subjects (hippocampus n = 18; PFC n = 25). Neuroplasticity-related proteins that form complexes with GPM6A were identified by coimmunoprecipitation technique followed by mass spectrometry. RESULTS: Results indicated transcriptional downregulation of GPM6A and GPM6B in the hippocampus of depressed suicides. The expression level of calcium/calmodulin-dependent protein kinase II alpha (CAMK2A) and coronin1A (CORO1A) was also significantly decreased. Subsequent analysis of coexpression patterns demonstrated coordinated gene expression in the hippocampus and in the PFC indicating that the function of these genes might be coregulated in the human brain. However, in the brain of depressed suicides this coordinated response was disrupted. CONCLUSIONS: Disruption of coordinated gene expression as well as abnormalities in GPM6A and GPM6B expression and expression of the components of GPM6A complexes were detected in the brain of depressed suicides.
BACKGROUND: Expression of the neuronal membrane glycoprotein M6a (GPM6A), the proteolipid protein (PLP/DM20) family member, is downregulated in the hippocampus of chronically stressed animals. Its neuroplastic function involves a role in neurite formation, filopodium outgrowth and synaptogenesis through an unknown mechanism. Disruptions in neuroplasticity mechanisms have been shown to play a significant part in the etiology of depression. Thus, the current investigation examined whether GPM6A expression is also altered in humandepressed brain. METHODS: Expression levels and coexpression patterns of GPM6A, GPM6B, and PLP1 (two other members of PLP/DM20 family) as well as of the neuroplasticity-related genes identified to associate with GPM6A were determined using quantitative polymerase chain reaction (qPCR) in postmortem samples from the hippocampus (n = 18) and the prefrontal cortex (PFC) (n = 25) of depressed suicide victims and compared with control subjects (hippocampus n = 18; PFC n = 25). Neuroplasticity-related proteins that form complexes with GPM6A were identified by coimmunoprecipitation technique followed by mass spectrometry. RESULTS: Results indicated transcriptional downregulation of GPM6A and GPM6B in the hippocampus of depressed suicides. The expression level of calcium/calmodulin-dependent protein kinase II alpha (CAMK2A) and coronin1A (CORO1A) was also significantly decreased. Subsequent analysis of coexpression patterns demonstrated coordinated gene expression in the hippocampus and in the PFC indicating that the function of these genes might be coregulated in the human brain. However, in the brain of depressed suicides this coordinated response was disrupted. CONCLUSIONS: Disruption of coordinated gene expression as well as abnormalities in GPM6A and GPM6B expression and expression of the components of GPM6A complexes were detected in the brain of depressed suicides.
Authors: Julieta Alfonso; Luciana R Frick; Dafne M Silberman; María L Palumbo; Ana M Genaro; Alberto C Frasch Journal: Biol Psychiatry Date: 2005-09-02 Impact factor: 13.382
Authors: Melisa C Monteleone; Ezequiela Adrover; María Eugenia Pallarés; Marta C Antonelli; Alberto C Frasch; Marcela A Brocco Journal: Epigenetics Date: 2013-08-19 Impact factor: 4.528
Authors: Anne Gregor; Jamie M Kramer; Monique van der Voet; Ina Schanze; Steffen Uebe; Rogier Donders; André Reis; Annette Schenck; Christiane Zweier Journal: Hum Mutat Date: 2014-12 Impact factor: 4.878
Authors: Tatyana Svitkina; Wan-Hsin Lin; Donna J Webb; Ryohei Yasuda; Gary A Wayman; Linda Van Aelst; Scott H Soderling Journal: J Neurosci Date: 2010-11-10 Impact factor: 6.167
Authors: Melisa C Monteleone; María Eugenia Pallarés; Silvia C Billi; Marta C Antonelli; Marcela A Brocco Journal: J Mol Neurosci Date: 2018-06-22 Impact factor: 3.444
Authors: Sandra Sanchez-Roige; Pierre Fontanillas; Sarah L Elson; Anita Pandit; Ellen M Schmidt; Johanna R Foerster; Gonçalo R Abecasis; Joshua C Gray; Harriet de Wit; Lea K Davis; James MacKillop; Abraham A Palmer Journal: Nat Neurosci Date: 2017-12-11 Impact factor: 24.884
Authors: Joshua C Gray; Sandra Sanchez-Roige; Harriet de Wit; James MacKillop; Abraham A Palmer Journal: Behav Processes Date: 2019-03-12 Impact factor: 1.777
Authors: Tamara Tanos; Alberto Maria Saibene; Carlotta Pipolo; Paolo Battaglia; Giovanni Felisati; Alicia Rubio Journal: PLoS One Date: 2017-07-18 Impact factor: 3.240
Authors: Micaela D Garcia; Karina Formoso; Gabriela I Aparicio; Alberto C C Frasch; Camila Scorticati Journal: Front Mol Neurosci Date: 2017-09-20 Impact factor: 5.639